OCULAR THERAPEUTIX, INC Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Ocular Therapeutix, Inc quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • Ocular Therapeutix, Inc Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 157M shares, a 97.3% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 157M +77.2M +97.3% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 156M +76.4M +96.4% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 155M +77.2M +99.6% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 115M +37.8M +48.9% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 79.4M +2.4M +3.12% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 79.2M +2.32M +3.02% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 77.5M +757K +0.99% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 77.2M +470K +0.61% Dec 31, 2022 10-K 2024-03-11
Q3 2022 77M +403K +0.53% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 76.9M +455K +0.6% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 76.8M +523K +0.69% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 76.7M +735K +0.97% Dec 31, 2021 10-K 2023-03-06
Q3 2021 76.6M +13.5M +21.5% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 76.5M +13.5M +21.4% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 76.2M +23.2M +43.7% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 76M +25.7M +51% Dec 31, 2020 10-K 2022-02-28
Q3 2020 63.1M +15M +31.2% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 63M +18.9M +42.7% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 53M +10.2M +23.8% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 50.3M +8.82M +21.2% Dec 31, 2019 10-K 2021-03-11
Q3 2019 48.1M +7.56M +18.6% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 44.1M +5.62M +14.6% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 42.8M +5.56M +14.9% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 41.5M +11.9M +40% Dec 31, 2018 10-K 2020-03-12
Q3 2018 40.5M +11.1M +37.9% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 38.5M +9.42M +32.4% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 37.3M +8.35M +28.8% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 29.7M +4.63M +18.5% Dec 31, 2017 10-K 2019-03-07
Q3 2017 29.4M +4.51M +18.1% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 29.1M +4.23M +17.1% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 28.9M +4.18M +16.9% Mar 31, 2017 10-Q 2017-05-05
Q4 2016 25M +274K +1.11% Dec 31, 2016 10-K 2018-03-08
Q3 2016 24.9M +150K +0.61% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 24.8M +102K +0.41% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 24.8M +3.33M +15.5% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 24.8M +3.42M +16% Dec 31, 2015 10-K 2017-03-10
Q3 2015 24.7M +3.41M +16% Sep 30, 2015 10-Q 2015-11-10
Q2 2015 24.7M +21.6M +690% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 21.4M Mar 31, 2015 10-Q 2015-05-15
Q4 2014 21.3M +18.7M +697% Dec 31, 2014 10-K 2016-03-10
Q3 2014 21.3M Sep 30, 2014 10-Q 2014-11-12
Q2 2014 3.13M Jun 30, 2014 10-Q 2014-08-29
Q4 2013 2.68M Dec 31, 2013 10-K 2015-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.